摘要
David Sudarto OEIRIA 医师
皮肤科医师
Beyond the epidermis: a multimodal algorithm approach to melasma in asian skin
目标: Melasma in Asian skin (Fitzpatrick III-V) is a chronic neurovascular-melanocytic disorder where destructive monotherapies often trigger severe PIH and rapid rebound. This lecture proposes a multimodal concurrent algorithm. We introduce the safe, first-line integration of 1064 nm picosecond laser toning and fractional 1064 nm picosecond lasers to actively remodel the dermal microenvironment. Coupled with early oral TXA, LADD via fractional 1927 nm thulium lasers, and strict barrier reconstruction, this approach addresses all root causes to yield sustained clearance.
介绍: For decades, treating melasma in Asian skin (Fitzpatrick III-V) has relied on epidermal destruction. These outdated monotherapies trigger hyper-reactive melanocytes, inevitably causing severe post-inflammatory hyperpigmentation (PIH) and rapid rebound. To achieve sustained clearance, we must re-evaluate the pathogenesis. Melasma is not a mere surface stain; it is a chronic neurovascular-melanocytic disorder driven by a compromised dermal microenvironment. This lecture challenges traditional algorithms, shifting the focus from surface destruction to deep, multimodal structural repair.
材料 / 方法: Clinical preliminary study
结果: safe and effective
总结: In conclusion, managing melasma in Asian skin requires a fundamental shift: viewing it as a chronic neurovascular-melanocytic disorder. By prioritizing deep dermal remodeling with early 1064 nm 300 ps picosecond laser toning and fractional with focal length -1 to -2 mm beyond the surface, coupled with oral TXA, 1927 nm Thulium LADD, and strict barrier reconstruction, we move beyond temporary fixes. This concurrent, multimodal algorithm effectively breaks the cycle of inflammation and rebound, delivering sustained, long-term clearance for our patients.
披露 - David Sudarto OEIRIA
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
评论 (0)
加入 IMCAS 学院社群!